333
Views
7
CrossRef citations to date
0
Altmetric
Drug Profile

Ustekinumab: moving the target from psoriasis to Crohn's disease

, , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Teodora-Ecaterina M Manuc, Mircea M Manuc & Mircea M Diculescu. (2016) Recent insights into the molecular pathogenesis of Crohn’s disease: a review of emerging therapeutic targets. Clinical and Experimental Gastroenterology 9, pages 59-70.
Read now

Articles from other publishers (6)

Alessandro Poggi, Roberto Benelli, Roberta Venè, Delfina Costa, Nicoletta Ferrari, Francesca Tosetti & Maria Raffaella Zocchi. (2019) Human Gut-Associated Natural Killer Cells in Health and Disease. Frontiers in Immunology 10.
Crossref
Huiling Wang, Kang Chao, Siew Chien Ng, Alfa Hc Bai, Qiao Yu, Jun Yu, Manying Li, Yi Cui, Minhu Chen, Ji-Fan Hu & Shenghong Zhang. (2016) Pro-inflammatory miR-223 mediates the cross-talk between the IL23 pathway and the intestinal barrier in inflammatory bowel disease. Genome Biology 17:1.
Crossref
Tal Engel & Uri Kopylov. (2016) Ustekinumab in Crohn’s disease: evidence to date and place in therapy. Therapeutic Advances in Chronic Disease 7:4, pages 208-214.
Crossref
Christel J Menet. (2014) Toward selective TYK2 inhibitors as therapeutic agents for the treatment of inflammatory diseases. Pharmaceutical Patent Analyst 3:4, pages 449-466.
Crossref
José Francisco Zambrano-Zaragoza, Enrique Jhonatan Romo-Martínez, Ma. de Jesús Durán-Avelar, Noemí García-Magallanes & Norberto Vibanco-Pérez. (2014) Th17 Cells in Autoimmune and Infectious Diseases. International Journal of Inflammation 2014, pages 1-12.
Crossref
Kai Sun, Natalie Buchan, Chris Larminie & Nataša Pržulj. (2014) The integrated disease network. Integr. Biol. 6:11, pages 1069-1079.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.